As of 2025-07-11, the Relative Valuation of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 959.87 INR. This relative valuation is based on P/E multiples. With the latest stock price at 557.90 INR, the upside of Lincoln Pharmaceuticals Ltd based on Relative Valuation is 72.1%.
The range of the Relative Valuation is 809.07 - 1,223.79 INR.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 22.4x | 21.6x |
| Forward P/E multiples | 15.5x - 21.9x | 18.5x |
| Fair Price | 809.07 - 1,223.79 | 959.87 |
| Upside | 45.0% - 119.4% | 72.1% |
| Date | P/E |
| 2025-07-10 | 13.57 |
| 2025-07-09 | 13.68 |
| 2025-07-08 | 13.70 |
| 2025-07-07 | 13.79 |
| 2025-07-04 | 13.70 |
| 2025-07-03 | 13.62 |
| 2025-07-02 | 13.57 |
| 2025-07-01 | 13.74 |
| 2025-06-30 | 13.72 |
| 2025-06-27 | 13.69 |
| 2025-06-26 | 13.67 |
| 2025-06-25 | 13.84 |
| 2025-06-24 | 13.61 |
| 2025-06-23 | 13.52 |
| 2025-06-20 | 13.74 |
| 2025-06-19 | 13.64 |
| 2025-06-18 | 13.97 |
| 2025-06-17 | 13.89 |
| 2025-06-16 | 14.05 |
| 2025-06-13 | 14.23 |
| 2025-06-12 | 14.57 |
| 2025-06-11 | 14.30 |
| 2025-06-10 | 14.07 |
| 2025-06-09 | 14.06 |
| 2025-06-06 | 13.92 |
| 2025-06-05 | 13.96 |
| 2025-06-04 | 13.29 |
| 2025-06-03 | 13.28 |
| 2025-06-02 | 13.37 |
| 2025-05-30 | 13.22 |
| 2025-05-29 | 13.16 |
| 2025-05-28 | 13.38 |
| 2025-05-27 | 13.36 |
| 2025-05-26 | 13.57 |
| 2025-05-23 | 13.58 |
| 2025-05-22 | 13.40 |
| 2025-05-21 | 14.84 |
| 2025-05-20 | 14.84 |
| 2025-05-19 | 14.67 |
| 2025-05-16 | 14.52 |
| 2025-05-15 | 14.71 |
| 2025-05-14 | 14.30 |
| 2025-05-13 | 14.37 |
| 2025-05-12 | 13.94 |
| 2025-05-09 | 13.50 |
| 2025-05-08 | 13.69 |
| 2025-05-07 | 13.82 |
| 2025-05-06 | 13.33 |
| 2025-05-05 | 13.72 |
| 2025-05-02 | 13.90 |